scholarly journals Prophylactic antibiotics to prevent pneumonia and other complications after measles: community based randomised double blind placebo controlled trial in Guinea-Bissau

BMJ ◽  
2016 ◽  
pp. i3040
BMJ ◽  
2006 ◽  
Vol 333 (7581) ◽  
pp. 1245 ◽  
Author(s):  
May-Lill Garly ◽  
Carlitos Balé ◽  
Cesário Lourenco Martins ◽  
Hilton C Whittle ◽  
Jens Nielsen ◽  
...  

2019 ◽  
Vol 32 (01) ◽  
pp. 010-017
Author(s):  
Ramesh Supadu Bawaskar ◽  
Vaishali Haribhau Shinde

Introduction Dengue ranks as the most important mosquito-borne viral disease in the world, with its incidence being increased 30-fold in the past 50 years. An epidemic of dengue/dengue haemorrhagic fever (DHF) is a major public health problem causing significant health and economic burden. The dengue crisis is further complicated by the lack of vaccines and antiviral drugs for prevention and control of this disease. This systematic review investigates and evaluates various studies done with homoeopathic therapy for the prevention and treatment of dengue fever. Objective Evaluate the usefulness of homoeopathy for a prevention and treatment of dengue fever through literature review and to develop the strategy for future research. Method A comprehensive search in electronic database aimed to target the available literature of observational studies, randomised trials, controlled trials, case studies on dengue fever in homoeopathy (excluding non–peer-reviewed journals) and limited to English language. Result A literary search through various databases helped identify a few significant studies as one double-blind placebo-controlled trial, one comparative clinical study, one case study and two community-based studies.The community-based studies showed positive results for the role of homoeopathic medicines as a prophylactic medicine. The double-blind placebo-controlled trial showed no difference in outcome between the two groups. The comparative clinical study showed that the homoeopathic combination appeared to be a more potent treatment against dengue fever when compare with standard maintenance therapy. The case study shows favourable results, but the sample size is only of 10 cases. Conclusion In future, high-quality randomised controlled trial (RCT), vitro and animal model studies are required to support the efficacy of homoeopathic therapeutics.


1997 ◽  
Vol 27 (8) ◽  
pp. 860-867 ◽  
Author(s):  
V.A. VARNEY ◽  
J. EDWARDS ◽  
K. TABBAH ◽  
H. BREWSTER ◽  
G. MAVROLEON ◽  
...  

2001 ◽  
Vol 120 (5) ◽  
pp. A384-A384
Author(s):  
L MOLLISON ◽  
L TOTTEN ◽  
C HOVELL ◽  
K THAYNE ◽  
C CONNELLY ◽  
...  

2007 ◽  
Vol 177 (4S) ◽  
pp. 14-15
Author(s):  
Brian J. DeCastro ◽  
Jack R. Walter ◽  
Leah P. McMann ◽  
Andrew C. Peterson

2012 ◽  
Vol 82 (4) ◽  
pp. 260-266 ◽  
Author(s):  
Salah E. Gariballa ◽  
Sarah J. Forster ◽  
Hilary J. Powers

Background: Although a number of studies have reported raised total plasma homocysteine (tHcy) concentrations in free-living older people, there are no data on homocysteine response to a mixed nutrient supplement in older patients. A raised plasma homocysteine concentration in older patients is partly a reflection of their co-morbidity, including impaired renal function, and there is uncertainty about the extent to which dietary interventions can improve plasma tHcy. Aim: To determine the plasma tHcy response to dietary supplements during acute illness. Methods: Two-hundred and thirty-six hospitalized, acutely ill older patients, who were part of a randomized double-blind placebo-controlled trial, were assigned to receive a daily oral nutritional supplement drink containing 1.3 mg of vitamin B2, 1.4 mg of vitamin B6, 1.5 μg of B12, 200 μg of folic acid, or a placebo, for 6 weeks. Outcome measures were plasma tHcy concentration at baseline, 6 weeks, and 6 months. Results: The mean plasma tHcy concentration fell among patients given the supplements (mean difference 4.1 µmol/L [95 % C.I, 0.14 to 8.03), p = 0.043], but tHcy concentration increased between 6 weeks and 6 months, after patients stopped taking the supplements [mean difference -2.0 µmol/L (95 % C.I, -03.9 to -0.18), p = 0.033]. About 46 % of patients in the placebo group and 55 % of patients in the supplement group had hyperhomocysteinemia (>14 µmol/L) at baseline compared with 45 % and 29 % at the end of the treatment period. Conclusions: A mixed nutrient supplement containing physiological amounts of B vitamins significantly reduced plasma tHcy concentrations in older patients recovering from acute illness.


Sign in / Sign up

Export Citation Format

Share Document